An observational study in Tuberculosis, sponsored by Epicentre. Completed. Open to participants aged 1 Month to 5 Years. Per ClinicalTrials.gov, last updated 2016-03-02.
Sponsored by Epicentre · Observational
The proposed study aims to establish a pilot program through a prospective cohort study offering routine contact tracing, investigation and prophylaxis for LTBI, and treatment of TB disease to children \<5 years living in the same household as adults diagnosed with smear/culture-positive pulmonary TB in Mbarara Regional Referral Hospital
Because children with tuberculosis (TB) are usually smear-negative and therefore less infectious, they are generally not considered a public health risk. Up to 70% of children living in the same household with an adult with infectious TB will become infected, and more than 20% of them will develop active TB disease, usually within 12 months. The individual risk of developing disease once infected is highest in children \<5 years. In addition, children under 5 years are at higher risk of developing disseminated forms of TB. The impact of childhood TB is worsened by co-infection with HIV. Contact tracing, investigation and prophylaxis of childhood contacts of adult TB cases are widely recommended but rarely practiced in developing countries. The World Health Organization recommends that all NTPs screen household contacts for symptoms of disease and offer isoniazid preventive therapy (i.e. daily isoniazid for at least 6 months) to children aged less than 5 years and to all HIV-infected children who are household contacts. In Mbarara, an area with a high incidence of TB, no program currently exists for the routine investigation of child contacts of adult pulmonary TB cases. Almost all child TB cases registered are found through the evaluation of symptomatic children, often long after the adult source-cases have been investigated and treated. The number of adult cases with pulmonary TB, together with the population structure in Mbarara (>50% of the total population being children) suggests that the number of childhood TB cases is probably higher than current hospital records indicate.
The proposed study aims to establish a pilot program through a prospective cohort study offering routine contact tracing, investigation and prophylaxis for LTBI, and treatment of TB disease to children \<5 years living in the same household as adults diagnosed with smear/culture-positive pulmonary TB in Mbarara Regional Referral Hospital. The study will also generate much needed data on the utility of simple symptom-based screening of child contacts for TB disease in areas where access to radiological examination and tuberculin skin test are limited and on the efficacy and safety of IPT, in a region with a significant problem of HIV co-infection.
Children aged 1 month to 5 years living in the same household (a house or cluster of houses on the same plot) with a newly diagnosed adult case of smear and/or culture-positive TB will be eligible for the study. Children will undergo a physical examination, chest Xray, tuberculin skin test and specimen collection in case of symptoms. Children will then be classified as active TB, TB infected and non infected cases. TB infected and non infected children will receive 6 months isoniazid prophylaxis with monthly monitoring of acceptability and tolerability. A final clinical assessment will be performed at 9 months. A total of 577 children contacts will be enrolled.
1,417 studies on the registry are indexed under Tuberculosis; 208 are open to participants now.
This study's enrollment of 281 is above the median of 250 across 421 observational studies indexed under Tuberculosis.
Browse Tuberculosis studies →Epicentre is the lead sponsor of 47 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Children aged 1 month to 5 years living in the same household (a house or cluster of houses on the same plot) with a newly diagnosed adult case of smear and/or culture-positive TB will be eligible for the study
Exclusion Criteria:
Proportion of <5 year-old child contacts classified as active TB disease, LTBI or no infection
Time frame: Baseline
Number of children <5 years exposed to TB in the household of adult index cases
Time frame: Baseline
Number of contacts identified as active TB basing on a symptom-based approach compared with those based on chest radiography
Time frame: 9 months
Proportion of contacts with HIV co-infection classified as non infected, LTBI or active TB
Time frame: 9 months
Median duration of exposure to symptomatic source case among the contacts in the various classes
Time frame: Baseline
Association of various risk factors with the final classification of contacts after assessment
Time frame: 9 months
Proportion of children with LTBI successfully treated (prevented from developing active TB disease) among HIV-infected and uninfected children
Time frame: 9 months
Proportion of children with no TB infection or disease successfully treated (prevented from developing active TB disease or LTBI)
Time frame: 9 months
Proportion of adverse events on treatment of TB disease, LTBI and TB exposure
Time frame: 9 months
Adherence to IPT regimens
Time frame: 9 months
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Epicentre